A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Rameh LE, Tolias KF, Duckworth BC, Cantley LC (1997) Nature 390: 192-6 Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Winder DG, Mansuy IM, Osman M, Moallem TM, Kandel ER (1998) Cell 92: 25-37 A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Odom AR, Stahlberg A, Wente SR, York JD (2000) Science 287: 2026-9 Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, Etemadmoghadam D, Bowtell D, Barretina J, Lin WM, Rameh L, Salmena L, Pandolfi PP, Cantley LC (2009) Cancer Cell 16: 115-25 PIPPing on AKT1: How Many Phosphatases Does It Take to Turn off PI3K? Toker A, Rameh L (2015) Cancer Cell 28: 143-5 Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Alagarsamy S, Marino MJ, Rouse ST, Gereau RW, Heinemann SF, Conn PJ (1999) Nat Neurosci 2: 234-40 A novel phosphatidylinositol(3,4,5)P3 pathway in fission yeast. Mitra P, Zhang Y, Rameh LE, Ivshina MP, McCollum D, Nunnari JJ, Hendricks GM, Kerr ML, Field SJ, Cantley LC, Ross AH (2004) J Cell Biol 166: 205-11 Overexpression of the inositol phosphatase SopB in human 293 cells stimulates cellular chloride influx and inhibits nuclear mRNA export. Feng Y, Wente SR, Majerus PW (2001) Proc Natl Acad Sci U S A 98: 875-9 Primary cilia signaling mediates intraocular pressure sensation. Luo N, Conwell MD, Chen X, Kettenhofen CI, Westlake CJ, Cantor LB, Wells CD, Weinreb RN, Corson TW, Spandau DF, Joos KM, Iomini C, Obukhov AG, Sun Y (2014) Proc Natl Acad Sci U S A 111: 12871-6 The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation. Carricaburu V, Lamia KA, Lo E, Favereaux L, Payrastre B, Cantley LC, Rameh LE (2003) Proc Natl Acad Sci U S A 100: 9867-72 Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ (1998) Biol Psychiatry 44: 169-78 Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Bianco R, Shin I, Ritter CA, Yakes FM, Basso A, Rosen N, Tsurutani J, Dennis PA, Mills GB, Arteaga CL (2003) Oncogene 22: 2812-22 Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1). Turturro F, Frist AY, Arnold MD, Seth P, Pulford K (2001) Oncogene 20: 4466-75 Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA (2004) Neurobiol Dis 17: 219-36 Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN. Mandl A, Sarkes D, Carricaburu V, Jung V, Rameh L (2007) Mol Cell Biol 27: 8098-112 Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII. Huke S, Bers DM (2007) J Mol Cell Cardiol 42: 590-9 Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation. Zhuang G, Hunter S, Hwang Y, Chen J (2007) J Biol Chem 282: 2683-94 O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. Wells L, Kreppel LK, Comer FI, Wadzinski BE, Hart GW (2004) J Biol Chem 279: 38466-70 Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. Abel TW, Baker SJ, Fraser MM, Tihan T, Nelson JS, Yachnis AT, Bouffard JP, Mena H, Burger PC, Eberhart CG (2005) J Neuropathol Exp Neurol 64: 341-9 Multiple pathways involved in the biosynthesis of anandamide. Liu J, Wang L, Harvey-White J, Huang BX, Kim HY, Luquet S, Palmiter RD, Krystal G, Rai R, Mahadevan A, Razdan RK, Kunos G (2008) Neuropharmacology 54: 1-7 Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer. McKinley ET, Liu H, McDonald WH, Luo W, Zhao P, Coffey RJ, Hanks SK, Manning HC (2013) PLoS One 8: e80207 Structures of KaiC circadian clock mutant proteins: a new phosphorylation site at T426 and mechanisms of kinase, ATPase and phosphatase. Pattanayek R, Mori T, Xu Y, Pattanayek S, Johnson CH, Egli M (2009) PLoS One 4: e7529 Target sizes of galactosyltransferase, sialyltransferase, and uridine diphosphatase in Golgi apparatus of rat liver. Fleischer B, McIntyre JO, Kempner ES (1993) Biochemistry 32: 2076-81 The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma. Wan XW, Jiang M, Cao HF, He YQ, Liu SQ, Qiu XH, Wu MC, Wang HY (2003) J Cancer Res Clin Oncol 129: 100-6 Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Huke S, Bers DM (2008) Biochem Biophys Res Commun 376: 80-5 On the contractile function of protein phosphatases in isolated human coronary arteries. Knapp J, Bokník P, Deng MC, Huke S, Lüss I, Klein-Wiele O, Linck B, Lüss H, Müller FU, Nacke P, Scheld HH, Schmitz W, Vahlensieck U, Neumann J (1999) Naunyn Schmiedebergs Arch Pharmacol 360: 464-72
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.